When do you recommend preoperative chemotherapy or hormonal therapy for ER+ breast cancer?

While trying to downstage the patient's tumor to make her a better candidate for breast-conserving surgery or to improve her cosmetic outcome is the primary reason why I administer neoadjuvant therapy in patients with HR+/HER2- breast cancers, there are occasionally other reasons, including delaying...